Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome in the United States. The company develops Nautilus Voyager Platform, which includes an end-to-end solution comprising...
44 insider purchases on record · latest filing 2026-03-04.
Insiders have also filed 4 sale transactions at NAUT.